Werewolf Therapeutics, Inc. - Common Stock, $0.0001 par value per share (HOWL)

CUSIP: 95075A107

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+3,787,065
Put/Call ratio
2.7%
SEC-reported price per share
$3.86
Indexed holders
41
Value change
+$14,923,168
Number of buys
23
Open additional details 1 more signal available
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,566,310

Security key

95075A107

Report period

Q4 2023

Indexed institutions

41

Top holders

10

Ownership snapshot

Top reported holders of HOWL - Werewolf Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $13,150,045 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $13.15M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $13.15M
MPM ASSET MANAGEMENT LLC $9.17M
PFM Health Sciences, LP $5.47M
MPM BioImpact LLC $5.11M
Rubric Capital Management LP $4.14M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$13,150,045
6,144,881 shares
— 30 Sep 2023
MPM ASSET MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$9,168,128
4,284,172 shares
— 30 Sep 2023
PFM Health Sciences, LP
13F
Company
13F
—
denominator unverified
$5,474,723
2,558,282 shares
— 30 Sep 2023
MPM BioImpact LLC
13F
Company
13F
—
denominator unverified
$5,110,344
2,388,011 shares
— 30 Sep 2023
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$4,141,664
1,935,357 shares
— 30 Sep 2023
BANK OF AMERICA CORP /DE/
13F
Company
13F
—
denominator unverified
$3,278,318
1,531,924 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
41
Shares
27,669,999
Indexed holders
41
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
34
Q4 2023 indexed holders
41
Indexed holder difference
7
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .